Clinical Trial Update: Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]

View source ↗

Summary

Phase 2 trial of Vedolizumab IV in pediatric patients with Ulcerative Colitis or Crohn's Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-12-21